You are here: Home: Meet The Professors - Breast Cancer 1 | 2009: Case 3: Select Publications

Select Publications

Konecny GE et al. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients. Clin Cancer Res 2004;10(5):1706-16. Abstract

Pegram M et al. Phase II combined biological therapy targeting the HER2 proto-oncogene and the vascular endothelial growth factor using trastuzumab (T) and bevacizumab (B) as first line treatment of HER2-amplified breast cancer. San Antonio Breast Cancer Symposium 2006;Abstract 301.

Pinder MC et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 2007;25(25):3808-15. Abstract

Slamon D et al. Phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2 positive early breast cancer patients: BCIRG 006 study. San Antonio Breast Cancer Symposium 2005.No Abstract available.

Swain SM et al. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer 2003;97(11):2869-79. Abstract

Yardley DA et al. Preliminary safety results: Addition of bevacizumab to 3 docetaxel regimens as adjuvant therapy for early stage breast cancer. Poster. San Antonio Breast Cancer Symposium 2008;Abstract 4107.